Rapid Pathogen Screening
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Rapid Pathogen Screening sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Rapid Pathogen Screening: 5 sponsored US clinical trials, none currently recruiting.
Rapid Pathogen Screening sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. The most-studied condition in this pipeline is Dysfunctional Tear Syndrome, with 1 trials.
Upper-quartile sponsor footprint
Rapid Pathogen Screening sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
FebriDx DISRUPT Acute Respiratory Infection Trial in Acute Respiratory Infection: An Evaluation of FebriDx® POC Test
NCT02018198
Clinical Evaluation of the InflammaDry Device for Detecting Dry Eye
NCT01692964
RPS InflammaDry Detector™ to Determine MMP-9 Levels in Tears
NCT01313351
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
NCT00921895
Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears
NCT00266734
Therapeutic Areas
How the Rapid Pathogen Screening archive is shaped
5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Dysfunctional Tear Syndrome (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Rapid Pathogen Screening: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Rapid Pathogen Screening sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Rapid Pathogen Screening page
5 registered trials is a research-attention snapshot, not an endorsement of Rapid Pathogen Screening or any single study.
- None of Rapid Pathogen Screening's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Dysfunctional Tear Syndrome is the condition Rapid Pathogen Screening studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dysfunctional Tear Syndrome trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rapid Pathogen Screening pipeline card: 5 registered trials from official public datasets.Report a data error.